These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
301 related items for PubMed ID: 24582836
1. Viral-human chimeric transcript predisposes risk to liver cancer development and progression. Lau CC, Sun T, Ching AK, He M, Li JW, Wong AM, Co NN, Chan AW, Li PS, Lung RW, Tong JH, Lai PB, Chan HL, To KF, Chan TF, Wong N. Cancer Cell; 2014 Mar 17; 25(3):335-49. PubMed ID: 24582836 [Abstract] [Full Text] [Related]
2. Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122. Liang HW, Wang N, Wang Y, Wang F, Fu Z, Yan X, Zhu H, Diao W, Ding Y, Chen X, Zhang CY, Zen K. J Hepatol; 2016 Feb 17; 64(2):278-291. PubMed ID: 26409216 [Abstract] [Full Text] [Related]
3. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma. Ding SL, Yang ZW, Wang J, Zhang XL, Chen XM, Lu FM. World J Gastroenterol; 2015 May 28; 21(20):6317-28. PubMed ID: 26034368 [Abstract] [Full Text] [Related]
4. Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations. Toh ST, Jin Y, Liu L, Wang J, Babrzadeh F, Gharizadeh B, Ronaghi M, Toh HC, Chow PK, Chung AY, Ooi LL, Lee CG. Carcinogenesis; 2013 Apr 28; 34(4):787-98. PubMed ID: 23276797 [Abstract] [Full Text] [Related]
5. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma. Deng X, Zhao XF, Liang XQ, Chen R, Pan YF, Liang J. Biomed Pharmacother; 2017 Jun 28; 90():100-108. PubMed ID: 28343069 [Abstract] [Full Text] [Related]
6. LINE(1)s of evidence in HBV-driven liver cancer. Heikenwalder M, Protzer U. Cell Host Microbe; 2014 Mar 12; 15(3):249-50. PubMed ID: 24629329 [Abstract] [Full Text] [Related]
7. No expression of HBV-human chimeric fusion transcript (HBx-LINE1) among Vietnamese patients with HBV-associated hepatocellular carcinoma. Trung NT, Hai LT, Giang DP, Hoan PQ, Binh MT, Hoan NX, Toan NL, Meyer CG, Velavan TP, Bang MH, Song LH. Ann Hepatol; 2019 Mar 12; 18(2):404-405. PubMed ID: 31036498 [No Abstract] [Full Text] [Related]
8. Differentially expressed genes associated with hepatitis B virus HBx and MHBs protein function in hepatocellular carcinoma. Kim DG. Methods Mol Biol; 2006 Mar 12; 317():141-55. PubMed ID: 16264227 [Abstract] [Full Text] [Related]
9. Expression of integrated hepatitis B virus X variants in human hepatocellular carcinomas and its significance. Chen WN, Oon CJ, Leong AL, Koh S, Teng SW. Biochem Biophys Res Commun; 2000 Oct 05; 276(3):885-92. PubMed ID: 11027564 [Abstract] [Full Text] [Related]
10. Hepatitis B virus X protein promotes the stem-like properties of OV6+ cancer cells in hepatocellular carcinoma. Wang C, Wang MD, Cheng P, Huang H, Dong W, Zhang WW, Li PP, Lin C, Pan ZY, Wu MC, Zhou WP. Cell Death Dis; 2017 Jan 19; 8(1):e2560. PubMed ID: 28102846 [Abstract] [Full Text] [Related]
11. [Polymorphism of hepatitis B virus x gene in hepatocellular carcinoma patients and the biological effects of HBx gene with deletion varations on QSG7701 cells]. Zhu PA, Tan DM, Peng ZT, Liu F, Song L. Zhonghua Gan Zang Bing Za Zhi; 2008 Jan 19; 16(1):7-11. PubMed ID: 18226335 [Abstract] [Full Text] [Related]
12. Hepatitis B virus X protein induced expression of the Nur77 gene. Lee MO, Kang HJ, Cho H, Shin EC, Park JH, Kim SJ. Biochem Biophys Res Commun; 2001 Nov 16; 288(5):1162-8. PubMed ID: 11700033 [Abstract] [Full Text] [Related]
13. Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/β-catenin signaling. Hsieh A, Kim HS, Lim SO, Yu DY, Jung G. Cancer Lett; 2011 Jan 28; 300(2):162-72. PubMed ID: 20971552 [Abstract] [Full Text] [Related]
14. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma. Yeh CT, Shen CH, Tai DI, Chu CM, Liaw YF. Oncogene; 2000 Nov 02; 19(46):5213-20. PubMed ID: 11077437 [Abstract] [Full Text] [Related]
15. [Inhibition of HBV DNA replication and expression in 2.2.15 hepatoma cells infected with AFP-mediated HBX antisense RNA]. Ma CH, Sun WS, Liu SX, Wang XY, Zhang LN, Cao YL, Han LH. Zhonghua Gan Zang Bing Za Zhi; 2003 May 02; 11(5):291-4. PubMed ID: 12773245 [Abstract] [Full Text] [Related]
16. [Gene expression profile in response to hepatitis B virus X gene by using an adenoviral vector]. Joo HY, Han KH, Ryu WS. Taehan Kan Hakhoe Chi; 2002 Dec 02; 8(4):371-80. PubMed ID: 12506241 [Abstract] [Full Text] [Related]
17. Comprehensive analysis of transcriptome profiles in hepatocellular carcinoma. Jin Y, Lee WY, Toh ST, Tennakoon C, Toh HC, Chow PK, Chung AY, Chong SS, Ooi LL, Sung WK, Lee CG. J Transl Med; 2019 Aug 20; 17(1):273. PubMed ID: 31429776 [Abstract] [Full Text] [Related]
18. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma. Qiu X, Dong S, Qiao F, Lu S, Song Y, Lao Y, Li Y, Zeng T, Hu J, Zhang L, Zhang L, Fan H. Oncogene; 2013 Jul 04; 32(27):3296-305. PubMed ID: 23604124 [Abstract] [Full Text] [Related]
19. Molecular mechanisms of HBV-associated hepatocarcinogenesis. Guerrieri F, Belloni L, Pediconi N, Levrero M. Semin Liver Dis; 2013 May 04; 33(2):147-56. PubMed ID: 23749671 [Abstract] [Full Text] [Related]
20. RNA identity crisis: hepatitis B walks the LINE. Niknafs YS, Chinnaiyan AM. Cancer Cell; 2014 Mar 17; 25(3):259-60. PubMed ID: 24651004 [Abstract] [Full Text] [Related] Page: [Next] [New Search]